Pharvaris is a clinical-stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients. The company provides alternatives to injected therapies for all sub-types of hereditary angioedema (HAE) and other B2 receptor-mediated indications.
|Employees (est.) (Feb 2020)||9||(+80%)|
Pharvaris total Funding
Pharvaris latest funding size
Time since last funding
|5 months ago|
|Venrock, Idinvest Partners, Foresite Capital, venBio Partners, Bain Capital Life Sciences, Kurma Partners, Life Science Partners|
When was Pharvaris founded?
Pharvaris was founded in 2015.
Who are Pharvaris key executives?
Pharvaris's key executives are Berndt Modig, Jochen Knolle and Morgan Conn.
How many employees does Pharvaris have?
Pharvaris has 9 employees.
Who are Pharvaris competitors?
Competitors of Pharvaris include Auriga Research, SRL and Romvac.
Where is Pharvaris headquarters?
Pharvaris headquarters is located at Leiden Bio Science Park J.H. Oortweg 21, Leiden.
Where are Pharvaris offices?
Pharvaris has an office in Leiden.
How many offices does Pharvaris have?
Pharvaris has 1 office.
Receive alerts for 300+ data fields across thousands of companies